Thus, upregulation of the miR-182-5p/FGF21/acetylcholine/PKA axis may be an effective approach to ameliorate obesity-induced metabolic diseases. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.